Nectero Medical
Tempe
About Nectero Medical
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $115.5M
- Funding stage: Late Stage Venture
- Last round: Series D (Apr 2024)
- Website: necteromedical.com
- Phone: 866-755-4744
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nectero-medical-53299 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.